Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01004354 · ClinicalTrials.gov registry record · NA
Vitamin D Supplementation in Psychiatric Illnesses
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01004354 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 12 participants.
The verdict
NCT01004354, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Children and adolescents with psychiatric illnesses who are treated with medications called second generation antipsychotic agents (SGA) often gain excessive weight during their treatment with these medications. This weight gain may result in the development of features of the metabolic syndrome or frank diabetes mellitus. There is no consensus on the best way to prevent these complications. The investigators' hypothesis is that daily vitamin D supplementation in these patients will result in decreased levels of the markers of metabolic syndrome with associated reduction in waist circumference.
Interventions
- DRUG Ergocalciferols
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01004354
The ClinicalTrials.gov registry entry for NCT01004354 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ergocalciferols is the first listed.
NCT01004354 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01004354 about?
NCT01004354 is a clinical study titled "Vitamin D Supplementation in Psychiatric Illnesses". Children and adolescents with psychiatric illnesses who are treated with medications called second generation antipsychotic agents (SGA) often gain excessive weight during their treatment with these medications. This weight gain may result in the development of features of the metabolic syndrome or ...
What is the current status of trial NCT01004354?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2009-06. Estimated completion is 2010-06.
What interventions are being tested in trial NCT01004354?
The interventions under investigation include: Ergocalciferols (DRUG).
Who is sponsoring clinical trial NCT01004354?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.